High Intensity Focused Ultrasound Market Size, Share & Trends Analysis Report By Application (Dermatology, Uterine Fibroids), By End-use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

High Intensity Focused Ultrasound Market Size, Share & Trends Analysis Report By Application (Dermatology, Uterine Fibroids), By End-use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030


High Intensity Focused Ultrasound Market Growth & Trends

The global high intensity focused ultrasound market size is anticipated to reach USD 1.97 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 7.06% during the forecast period, 2024 to 2030. The increasing prevalence of cancer and other chronic diseases, coupled with the growing demand for non-invasive treatment options, is expected to drive market growth. In addition, advancements in high intensity focused ultrasound (HIFU) technology and increasing research activities are contributing to the market expansion.

The rise in cancer cases worldwide is a significant driver for the HIFU market. HIFU offers a non-invasive alternative to traditional cancer treatments, such as surgery and radiation therapy, leading to higher adoption rates. Continuous innovations in HIFU technology, including the integration of artificial intelligence and improved imaging techniques, are enhancing the efficacy and precision of treatments, thereby boosting market growth. Increasing preference for non-invasive procedures among patients due to reduced recovery times, lower risk of infections, and minimal hospital stays is expected to propel the HIFU market. Beyond oncology, HIFU is being explored for treating other conditions, such as uterine fibroids, neurological disorders, and cosmetic applications, opening new avenues for market growth.

Furthermore, as the global burden of chronic diseases, HIFU's role in providing a non-invasive treatment option is becoming crucial in managing these conditions, driving market demand. Patients and healthcare providers are increasingly favoring non-invasive treatments due to their numerous benefits, such as reduced pain, shorter recovery periods, and decreased healthcare costs. Ongoing advancements in HIFU technology, including the development of more precise and efficient ultrasound devices, are enhancing treatment outcomes and expanding the potential applications of HIFU.

High Intensity Focused Ultrasound Market Report Highlights
  • In 2023, the dermatology application segment dominated the market by capturing over 20% of the market share. This is primarily attributed to the increasing adoption of HIFU technology for various aesthetic and therapeutic applications.
  • Among the end use, hospitals held a majority revenue share of 39.9% in 2023. This is owing to the adoption of technologically advanced medical devices by hospitals.
  • North America dominated the global market with a share of over 39% in 2023. This can be attributed to the presence of key market players and ongoing research and development activities in the region.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. High Intensity Focused Ultrasound (HIFU) Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Prevalence of Cancer and Other Chronic Diseases
3.2.1.2. Growing Preference for Minimally Invasive Procedures
3.2.1.3. Increasing Adoption in Non-Oncological Applications
3.2.1.4. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Equipment and Treatment
3.2.2.2. Availability of Alternative Method
3.3. High Intensity Focused Ultrasound (HIFU) Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. High Intensity Focused Ultrasound (HIFU) Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global High Intensity Focused Ultrasound (HIFU) Application Market Movement Analysis
4.3. Global High Intensity Focused Ultrasound (HIFU) Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Uterine Fibroids
4.4.1. Uterine Fibroids market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Prostate Cancer
4.5.1. Prostate Cancer market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Essential Tremor
4.6.1. Essential Tremor market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Dermatology
4.7.1. Dermatology market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Breast Cancer
4.8.1. Breast Cancer market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Glaucoma
4.9.1. Glaucoma market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Backpain, Facetogenic
4.10.1. Backpain, facetogenic market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Other Applications
4.11.1. Other applications market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. High Intensity Focused Ultrasound (HIFU) Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global High Intensity Focused Ultrasound (HIFU) End Use Market Movement Analysis
5.3. Global High Intensity Focused Ultrasound (HIFU) Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Imaging Centers
5.5.1. Imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Other End Users
5.6.1. Other end users market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. High Intensity Focused Ultrasound (HIFU) Market: Regional Estimates & Trend Analysis By Application, End Use
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Competitive scenario
6.5.1.3. Regulatory framework
6.5.1.4. Reimbursement structure
6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Competitive scenario
6.5.2.3. Regulatory framework
6.5.2.4. Reimbursement structure
6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Competitive scenario
6.5.3.3. Regulatory framework
6.5.3.4. Reimbursement structure
6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Competitive scenario
6.6.1.3. Regulatory framework
6.6.1.4. Reimbursement structure
6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement structure
6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement structure
6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Competitive scenario
6.6.4.3. Regulatory framework
6.6.4.4. Reimbursement structure
6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Competitive scenario
6.6.5.3. Regulatory framework
6.6.5.4. Reimbursement structure
6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Competitive scenario
6.6.6.3. Regulatory framework
6.6.6.4. Reimbursement structure
6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Competitive scenario
6.6.7.3. Regulatory framework
6.6.7.4. Reimbursement structure
6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Competitive scenario
6.6.8.3. Regulatory framework
6.6.8.4. Reimbursement structure
6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement structure
6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement structure
6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement structure
6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement structure
6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement structure
6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement structure
6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement structure
6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement structure
6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement structure
6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement structure
6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement structure
6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Competitive scenario
6.9.4.3. Regulatory framework
6.9.4.4. Reimbursement structure
6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2023
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators and Leaders
7.6. Company Profiles
7.6.1. Focal One
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Sonablate Corp.
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Verasonics, Inc.
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. ALPINION MEDICAL SYSTEMS Co., Ltd.
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Theraclion
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. Chongqing Haifu Medical Technology Co., Ltd.
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. ULTRAISER
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings